Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
1.990
-0.020 (-1.00%)
Nov 21, 2024, 3:36 PM EST - Market open
Can-Fite BioPharma Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$14.00
Upside
+603.52%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +804.52% | Nov 12, 2024 |
EF Hutton | EF Hutton | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +402.51% | Oct 10, 2024 |
EF Hutton | EF Hutton | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +402.51% | Sep 24, 2024 |
EF Hutton | EF Hutton | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +402.51% | Aug 30, 2024 |
EF Hutton | EF Hutton | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +402.51% | Jul 17, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +804.52% | May 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $18 | Strong Buy | Maintains | $34 → $18 | +804.52% | Oct 24, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +1,608.54% | Jun 2, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +1,608.54% | Mar 13, 2023 |
Aegis Capital | Aegis Capital | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +2,412.56% | Jun 24, 2021 |